Advertisement
"Christine is one of the most respected professionals in the industry, andwe are absolutely thrilled to be able to bring her to Michigan for the MichBioExpo," said Stephen Rapundalo, Ph.D., MichBio Executive Director. "At a timewhen the vision for Michigan's life sciences industry is coming into betterfocus, and we are recognizing what we need to capitalize on our strengths andsuccesses, it will be interesting and illuminating to have the benefit ofChristine's global perspective and experienced viewpoint."
Advertisement
Johnson & Johnson is a 122 year-old multinational conglomerate thatcontinues with leadership positions in consumer health products,pharmaceuticals, medical devices and biologics. Ms. Poon joined Johnson &Johnson in 2000 as Group Chairman in the Pharmaceuticals Group. She was namedWorldwide Chairman, Medicines & Nutritionals in 2003 and was appointed ViceChairman in 2005. In January of this year, she was named Worldwide Chairmanof the Pharmaceuticals Group. She is responsible for managing thepharmaceutical, consumer pharmaceutical and nutritional businesses of thecompany, in addition to overseeing its expanding R&D pipeline. She is also amember of the company's Executive Committee.
Prior to joining Johnson & Johnson, Ms. Poon served in various managementpositions at Bristol-Myers Squibb Company for 15 years, most recently asPresident of International Medicines (1998-2000) and President of MedicalDevices (1997-1998). She is a Director of Prudential Financial Inc., theUS-China Business Council, and the Fox Chase Cancer Center in Philadelphia PA.Ms. Poon received her BA in Biology from Northwestern University, her M.S. inBiology and Biochemistry from St. Louis University, and an MBA in Finance fromBoston University.
Expo Program Adds New Features
In addition to Ms. Poon's keynote address, this year's Expo provides arobust schedule of offerings covering two full days with several new programfeatures. Additions to the program include:
-- The Michigan Emerging Life Sciences Showcase, where the best ofMichigan's new and emerging life sciences companies will present before anaudience of venture capitalists, angel investors and institutional investors;
-- The Life Sciences Innovation and Commercialization Caucus, a roadmapping discussion of the future of the industry by legislators and lifesciences leaders from across the state;
-- Medical Device Suppliers Track focusing on manufacturing companieslooking to diversify or increase their business in the medical deviceindustry, and;
-- An exclusive members-only CEO dinner where life science leaders willnetwork with their peers and take part in a high-level discussion ofleadership issues facing the industry.
Other Expo events include one-on-one Business Partnering Meetings, companytours, R&D, Emerging Business and Medical Affairs and Markets sessions andworkshops, a breakfast forum, networking receptions, lunch and breaks.
More than 70% of those attending the MichBio Expo are executives in lifesciences companies, research institutions and universities with another 25%representing service providers and other related industries. The 2008 eventwill be held at the Rock Financial ShowPlace in Novi, MI. Registration forattendees opens September 1. For information, visithttp://www.michbio.org/Expo/.
MichBio is committed to driving the growth of Michigan's life scienceindustry and to fostering the collective impact of its members by serving as
